Cargando…

Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus

BACKGROUND: The prognostic impact of long-term glycemic variability on clinical outcomes in patients with heart failure (HF) and type 2 diabetes mellitus (T2DM) remains unclear. We determined and compared hemoglobin A1c (HbA1c) variability and clinical outcomes for patients with HF with preserved ej...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Jun, Pan, Jian-an, Fan, Yu-qi, Zhang, Hui-li, Zhang, Jun-feng, Wang, Chang-qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026342/ https://www.ncbi.nlm.nih.gov/pubmed/29960591 http://dx.doi.org/10.1186/s12933-018-0739-3

Ejemplares similares

HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients
por: Su, Jian-bin, et al.
Publicado: (2018)

Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes
por: Matsutani, Daisuke, et al.
Publicado: (2018)

Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial
por: Ceriello, Antonio, et al.
Publicado: (2020)

Longitudinal HbA(1c) trajectory modelling reveals the association of HbA(1c) and risk of hospitalization for heart failure for patients with type 2 diabetes mellitus
por: Tee, Clarence, et al.
Publicado: (2023)

The relationship between HbA(1c) and ultrasound plaque textures in atherosclerotic patients
por: Huang, Xiao-Wei, et al.
Publicado: (2016)

Association of Mean and Variability of HbA1c with Heart Failure in Patients with Type 2 Diabetes
por: Lin, You-Ting, et al.
Publicado: (2021)

Visit-to-visit HbA(1c) variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention
por: Yang, Chen Die, et al.
Publicado: (2020)

HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target
por: Ceriello, Antonio, et al.
Publicado: (2022)

Plasma metabolites mediate the effect of HbA1c on incident cardiovascular disease
por: Dong, Xuesi, et al.
Publicado: (2019)

Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes
por: Yang, Chun-Pai, et al.
Publicado: (2020)

HbA(1c) versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients
por: Hjellestad, Iren D, et al.
Publicado: (2013)

Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes
por: Yang, Chen-Yi, et al.
Publicado: (2020)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

How does HbA1c predict mortality and readmission in patients with heart failure? A protocol for systematic review and meta-analysis
por: Xu, Jun-Peng, et al.
Publicado: (2023)

Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients
por: Sia, Ching-Hui, et al.
Publicado: (2021)

Impact of long-term glycemic variability on development of atrial fibrillation in type 2 diabetic patients
por: Gu, Jun, et al.
Publicado: (2017)

Associations Between Mean HbA1c, HbA1c Variability, and Both Mortality and Macrovascular Complications in Patients with Diabetes Mellitus: A Registry-Based Cohort Study
por: Tan, Joshua Kuan, et al.
Publicado: (2023)

Association of long-term visit-to-visit variability of HbA1c and fasting glycemia with hypoglycemia in type 2 diabetes mellitus
por: Long, Chen, et al.
Publicado: (2022)

Association of HbA1c with hospitalization and mortality among patients with heart failure and diabetes
por: Blecker, Saul, et al.
Publicado: (2016)

An Emerging Diabetes Mellitus Diagnosis Modality: HbA(1c)
por: Seo, Hyun-Ae, et al.
Publicado: (2012)

Contemporary risk estimates of three HbA(1c) variables in relation to heart failure following diagnosis of type 2 diabetes
por: Skrtic, Stanko, et al.
Publicado: (2017)

HbA1C Variability and the Risk of Renal Status Progression in Diabetes Mellitus: A Meta-Analysis
por: Cheng, Dongsheng, et al.
Publicado: (2014)

The Effect of HbA(1c) Variability as a Risk Measure for Microangiopathy in Type 1 Diabetes Mellitus
por: Romero-Aroca, Pedro, et al.
Publicado: (2021)

Current Status of HbA1c Biosensors
por: Lin, Hua, et al.
Publicado: (2017)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022)

Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention
por: Nusca, Annunziata, et al.
Publicado: (2019)

Visit-to-visit HbA1c variability is associated with poor prognosis in peritoneal dialysis patients with type 2 diabetes mellitus
por: Zhang, Fengping, et al.
Publicado: (2023)

Cardiovascular Autonomic Neuropathy Predicts Higher HbA1c Variability in Subjects with Type 2 Diabetes Mellitus
por: Yang, Yeoree, et al.
Publicado: (2018)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

Standardization of the HbA(2) Assay
por: Paleari, Renata, et al.
Publicado: (2018)

Long-term HbA1c variability and macro-/micro-vascular complications in type 2 diabetes mellitus: a meta-analysis update
por: Sartore, Giovanni, et al.
Publicado: (2023)

Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting
por: Kassaian, Seyed Ebrahim, et al.
Publicado: (2012)

HbA1c at term delivery and adverse pregnancy outcome
por: Hong, Jesrine Gek Shan, et al.
Publicado: (2022)

The utility of HbA1c combined with haematocrit for early screening of gestational diabetes mellitus
por: Wu, Kui, et al.
Publicado: (2018)

Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c
por: Karayiannides, Stelios, et al.
Publicado: (2021)

The Influence of HbA1c and Gestational Weight Gain on Pregnancy Outcomes in Pregnant Women With Gestational Diabetes Mellitus
por: Zhang, Qiuhong, et al.
Publicado: (2022)

Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
por: Feng, Xiaojing, et al.
Publicado: (2021)

HbA1c and FIB-4 as serologic markers for the risk of progression of stage A heart failure
por: Grigg, William, et al.
Publicado: (2021)

HbA mutation causing false-normal HbA1c results determined by HPLC in a patient with type 2 diabetes mellitus: A case report
por: Wang, Juan, et al.
Publicado: (2021)

HbA1c below 7 % as the goal of glucose control fails to maximize the cardiovascular benefits: a meta-analysis
por: Wang, Pin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4p0ov6np4q1404co8hhqrtqhna